Related Experiment Video
Updated: May 18, 2026

06:06
In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
Non-covalent interaction between polyubiquitin and GTP cyclohydrolase 1 dictates its degradation
Yu Zhao1, Huaiping Zhu, Ming-Hui Zou
1Section of Molecular Medicine, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, Oklahoma, United States of America.
Plos One
|September 18, 2012
Summary
GTP cyclohydrolase 1 (GTPCH1) protein is degraded through a novel non-covalent interaction with polyubiquitin. This binding targets GTPCH1 for ubiquitination and proteasome degradation, impacting enzyme stability.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- GTP cyclohydrolase 1 (GTPCH1) is crucial for tetrahydrobiopterin (BH4) synthesis.
- GTPCH1 degradation is observed in diseases like diabetes and hypertension.
- Mechanisms of GTPCH1 degradation were previously unknown.
Purpose of the Study:
- To elucidate the molecular mechanisms of GTPCH1 protein degradation.
- To identify the interaction between GTPCH1 and its degradation machinery.
- To investigate the role of ubiquitination in GTPCH1 stability.
Main Methods:
- In vitro and in vivo biochemical assays.
- Ubiquitin-binding domain (UBD) analysis.
- Mutagenesis studies (Ile131).
- Proteasome inhibition assays.
Main Results:
- A novel non-covalent interaction between GTPCH1 and polyubiquitin was identified.
- Lys48-linked ubiquitin chains specifically bound GTPCH1, promoting degradation.
- Mutating an isoleucine in the GTPCH1 UBD impaired ubiquitin binding and enzyme stability.
- Proteasome inhibition reduced GTPCH1 degradation.
Conclusions:
- GTPCH1 non-covalently binds polyubiquitin via its UBD.
- This interaction facilitates GTPCH1 ubiquitination and subsequent proteasomal degradation.
- The findings reveal a new regulatory pathway for GTPCH1 stability.
Related Concept Videos
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
GTPases and their Regulation
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Large G-proteins, also known...

